{
    "pmcid": "7224157",
    "qa_pairs": {
        "What allele was identified as having favorable biophysical properties for the scaffold of the single-domain antibody library?": [
            "IGHV3-66*01",
            "IGHV1-69*01",
            "IGHV4-34*01",
            "IGHV2-70*01"
        ],
        "What is a key advantage of fully human-derived nanobodies compared to camelid-derived nanobodies?": [
            "Reduced immunogenicity",
            "Increased size",
            "Higher production cost",
            "Lower binding affinity"
        ],
        "What potential delivery method is highlighted for nanobodies due to their small size?": [
            "Inhalation delivery",
            "Intravenous injection",
            "Oral administration",
            "Topical application"
        ],
        "Which group of antibodies showed potent neutralization by targeting cryptic epitopes at the spike trimeric interface?": [
            "Group D",
            "Group A",
            "Group B",
            "Group C"
        ],
        "Which specific part of the SARS-CoV-2 virus was the antibody library panned against to identify nanobodies?": [
            "Spike protein's receptor-binding domain (RBD) and S1 subunit",
            "Nucleocapsid protein",
            "Membrane protein",
            "Envelope protein"
        ]
    }
}